The role of androgens in female sexual dysfunction

Sexuality, Reproduction and Menopause

Volumn 4, Issue 1, 2006, Pages 27-32

  Hollingsworth, Margarita ^a   Berman, Jennifer ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Rodeo Drive Women's Health Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRATEST; ESTROGEN; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE;

ACNE; ANDROGEN DEFICIENCY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTOSIS; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE ACTION; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; LIBIDO DISORDER; LIPID BLOOD LEVEL; LIVER TOXICITY; MEDICAL ASSESSMENT; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SIDE EFFECT; SLEEP APNEA SYNDROME; SYMPTOM; VIRILIZATION; VOICE; WELLBEING;

EID: 33846448536     PISSN: 15462501     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sram.2006.03.002     Document Type: Review

References (44)

1. Diokno A., Brown M., and Herzog A. Sexual function in the elderly. Arch Intern Med 150 (1990) 197-200
2. Mooradian A., and Greiff V. Sexuality in older women. Arch Intern Med 150 (1990) 1033-1038
3. Basson R., Berman J., Burnett A., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163 (2000) 888-893
4. Grumbach M., and Conte F. Disorders of sex differentiation. In: Wilson J., Foster D., Kronenburg H., et al. (Eds). Williams Textbook of Endocrinology. 9th ed. (1998), WB Saunders, Philadelphia, Pa 1303-1425
5. Labrie F., Belanger A., Cusan L., et al. Physiological changes in dehydroepiandrostenedione are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 8 (1997) 2403-2409
6. Padero M., Bhasin S., and Friedman T. Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc 50 (2002) 1131-1140
7. Burger N., and Johnson J. Androgen production in women. In: Tulandi T., and Gelfand M. (Eds). Androgens and Reproductive Aging (2006), Taylor and Francis, Abingdon, UK 1-4
8. Legrain S., Massien C., Lahlou N., et al. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 85 (2000) 3208-3217
9. Davis S. Androgen treatment in women. Med J Aust 170 (1999) 545-549
10. Yen S. Chronic anovulation caused by peripheral endocrine disorders. In: Yen S., Jaffe R., and Barbieri R. (Eds). Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 4th ed. (1999), WB Saunders, Philadelphia, Pa 479-515
11. Morales A., and Tenover J. Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin North Am 29 (2002) 975-982
12. Chen W., Zouboulis C., Fritsch M., et al. Evidence of heterogeneity and quantitative differences of the type 1 5α-reductase expression in cultured human skin cells-evidence of its presence in melanocytes. J Invest Dermatol 110 (1998) 84-89
13. Lombardi G., Zarrilli S., Colao A., et al. Estrogens and health in males. Mol Cell Endocrinol 178 (2001) 51-55
14. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 77 (2002) S34-S41
15. Abu E., Horner A., Kusec V., et al. The localization of androgen receptors in bone. J Clin Endocrinol Metab 82 (1997) 3493-3497
16. Zumoff B., Rosenfeld R., Strain G., et al. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51 (1980) 330-333
17. Orentreich N., Brind J., Rizer R., and Vogelman J. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration throughout adulthood. J Clin Endocrinol Metab 59 (1984) 551-555
18. Nappi R., Ferdeghini F., and Polatti F. Mechanisms involved in desire and arousal dysfunction. In: Goldstein I., Meston C., Davis S., and Traish A. (Eds). Women's Sexual Function and Dysfunction (2006), Taylor and Francis, Abingdon, UK 203-209
19. Nappi R., Detaddei S., Ferdeghini F., et al. Role of testosterone in feminine sexuality. J Endocrinol Invest 26 (2003) 97-101
20. Cardozo L., Bachmann G., McClish D., et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in post-menopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92 (1998) 722-727
21. Cunningham S., and McKenna T. Dissociation of adrenal androgens and cortisol secretion in Cushing's syndrome. Clin Endocrinol 41 (1994) 795-800 (Oxf)
22. Parker L., Levin E., and Lifrat E. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 60 (1985) 947-952
23. Johnson C., and Berman J. Androgen receptor expression in women and its relationship to sexual function. In: Tulandi T., and Gelfand M. (Eds). Androgens and Reproductive Aging (2006), Taylor and Francis, Abingdon, UK 29-41
24. Sherwin B., and Gelfand M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychom Med 49 (1987) 397-409
25. Traish A., Kim N., Min K., et al. Role of androgens in female genital sexual arousal: receptor expression, structure and function. Fertil Steril 77 (2002) S11-S18
26. Sourla A., Flamand M., Belanger A., et al. Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol 66 (1998) 137-149
27. Kennedy T., and Armstrong D. Induction of vaginal mucification in rats with testosterone and 17beta-hydroxy-5alpha-androstan-3-one. Steroids 27 (1976) 423-430
28. Hodgins M., Spike R., Mackie R., and Maclean A. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 105 (1998) 216-222
29. Berman J., Almeida F., Jolin J., et al. Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status. Fertil Steril 79 (2003) 925-931
30. Guay A., and Spark R. Pathophysiology of sex steroids in women. In: Goldstein I., Meston C., Davis S., and Traish A. (Eds). Women's Sexual Function and Dysfunction (2006), Taylor and Francis, Abingdon, UK 218-227
31. The North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause 12 (2005) 497-511
32. Granger D., Shirtcliff E., Booth A., et al. The "trouble" with salivary testosterone. Psychoneuroendocrinology 29 (2004) 1229-1240
33. Mortola J., and Yen S. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71 (1990) 696-704
34. Lobo R., Rosen R., Yang H., et al. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in post-menopausal women with hypoactive sexual desire. Fertil Steril 79 (2003) 1341-1352
35. Buckler H., Robertson W., and Wu F. Which androgen replacement therapy for women?. J Clin Endocrinol Metab 83 (1998) 3920-3924
36. Urman B., Pride S., and Yuen H. Elevated serum testosterone hirsutism and virilism associated with combined androgen-estrogen hormone replacement therapy. Obstet Gynecol 77 (1991) 595-598
37. Shifren J., Braunstein G., Simon J., et al. Transdermal testosterone treatment in women impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
38. Goldstat R., Briganti E., Tran J., et al. Transdermal testosterone improves mood, well-being and sexual function in premenopausal women. Menopause 10 (2003) 390-398
39. Lobo R. Androgens in postmenopausal women: production, possible role and replacement options. Obstet Gynecol Surv 56 (2001) 361-376
40. Westaby D., Ogle S., Paradinas F., et al. Liver damage from long-term methyltestosterone. Lancet 2 (1977) 262-263
41. Mani S., Allen J., Clark J., et al. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science 265 (1994) 1246-1249
42. Cragnolini A., Scinonelli T., Celis M., et al. The role of melanocortin receptors in the sexual behavior of female rats. Neuropeptides 34 (2000) 211-215
43. Rhoden E., and Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350 (2004) 482-492
44. Carrejo M., Culberson J., and Tan R. An introduction to androgen decline in aging males. In: Tulandi T., and Gelfand M. (Eds). Androgens and Reproductive Aging (2006), Taylor and Francis, Abingdon, UK 154-169